Certain information has been omitted from this exhibit in places marked “[***]” because it is both not material and would likely cause competitive harm to the registrant if publicly disclosed. In addition, certain personally identifiable information...Credit Agreement • February 28th, 2022 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 28th, 2022 Company Industry JurisdictionThis CREDIT AGREEMENT is entered into as of December 7, 2020 among BIOCRYST PHARMACEUTICALS, INC., a Delaware corporation (the “Borrower”), the Guarantors (defined herein) listed on the signature pages hereto and from time to time party hereto, the Lenders (defined herein) from time to time party hereto and ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP, a Delaware limited partnership, as Administrative Agent for the Lenders (each as defined below).
EXECUTION VERSION FOURTH AMENDMENT TO CREDIT AGREEMENT THIS FOURTH AMENDMENT TO CREDIT AGREEMENT (this “Agreement”) dated as of August 5, 2020 (the “Fourth Amendment Effective Date”) is entered into among ESTABLISHMENT LABS HOLDINGS INC., a BVI...Credit Agreement • August 10th, 2020 • Establishment Labs Holdings Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledAugust 10th, 2020 Company Industry Jurisdiction
THIRD AMENDMENT TO CREDIT AGREEMENT AND WAIVER THIS THIRD AMENDMENT TO CREDIT AGREEMENT AND WAIVER (this “Agreement”) dated as of June 17, 2019 (the “Third Amendment Effective Date”) is entered into among ESTABLISHMENT LABS HOLDINGS INC., a BVI...Credit Agreement • June 18th, 2019 • Establishment Labs Holdings Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledJune 18th, 2019 Company Industry Jurisdiction